Tech Company Financing Transactions
Trially AI Funding Round
Trially AI, based in Kansas City, received $4.7 million in investment from Flyover Capital, Alpaca VC and Blu Venture Investors.
Transaction Overview
Company Name
Announced On
9/17/2025
Transaction Type
Venture Equity
Amount
$4,700,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the adoption of its platform across research sites, pharmaceutical sponsors, CROs and physician networks.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
Undisclosed
Kansas City, MO 64113
USA
Kansas City, MO 64113
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Trially, we believe that Al isn't about automation for its own sake. It's about creating systems that work alongside us, making our jobs, and the challenges we solve for, more insightful and rewarding. Today, 86% of trials are delayed, wasting over $600K per day for sponsors and burdening sites. Instead of spending more money on ads, the real evidence-backed opportunity is in untapped patient data.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kyle McAllister
Chief Technical Officer
Ramon Prieto
VP - Product Management
Trevor Welch
Browse more venture capital transactions:
Prev: 9/17/2025: Colossal Biosciences venture capital transaction
Next: 9/17/2025: PassiveLogic venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs